{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:14312"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:14312","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Investigating the potential senomorphic properties of SCFA butyrate on aged T cells.","abstract":"Ageing is accompanied by remodelling of the T cell pool and a hallmark of immune ageing is the expansion of senescent T cells in aged hosts. Senescent T cells express markers of DNA damage and cell cycle arrest markers, elevated production of pro-inflammatory cytokines as a result of the senescence-associated secretory phenotype (SASP), and accumulation of dysfunctional mitochondria. Importantly, animal studies have brought to light the causal role of senescent T cell accumulation in driving ageing of non-lymphoid organs; highlighting the need to combat the build-up of senescent T cells with advancing age. Advancing age is also characterised by changes in gut microbiome composition, one consequence of which is a reduction in short-chain fatty acid (SCFA) levels, the products of bacterial fermentation in the gut. Interestingly, our group have reported a negative correlation between stool butyrate levels and senescent CD4 and CD8 T cells in older adults. To elucidate this connection further, in this thesis, we have examined the effect of butyrate on T cell senescent features in healthy young ( 35 years) and healthy old ( 65 years) adults using an in vitro model of proliferation-induced senescence. Evaluation of the potential anti-senescent effect of butyrate revealed significant reductions in the cell cycle arrest maker p53 and DNA damage marker -H2AX in aged T cells following 3 day culture with 1mM butyrate. We observed potential senomorphic properties of butyrate mediated via attenuation of SASP post butyrate treatment in aged T cells, alongside reductions in the expression of a key SASP regulator, the transcription factor nuclear factor kappa B (NF-B) at both the gene and protein level. Additionally, our findings demonstrated the potential ability of butyrate to decrease mitochondrial mass and ROS production in the T cells of older adults, however this requires further investigation. Consequently, we present butyrate supplementation as a future senomorphic postbiotic treatment to delay the onset of the senescent phenotype and help reduce the healthspan-lifespan gap by combating immunesenescence.","abstract_html":"Ageing is accompanied by remodelling of the T cell pool and a hallmark of immune ageing is the expansion of senescent T cells in aged hosts. Senescent T cells express markers of DNA damage and cell cycle arrest markers, elevated production of pro-inflammatory cytokines as a result of the senescence-associated secretory phenotype (SASP), and accumulation of dysfunctional mitochondria. Importantly, animal studies have brought to light the causal role of senescent T cell accumulation in driving ageing of non-lymphoid organs; highlighting the need to combat the build-up of senescent T cells with advancing age. Advancing age is also characterised by changes in gut microbiome composition, one consequence of which is a reduction in short-chain fatty acid (SCFA) levels, the products of bacterial fermentation in the gut. Interestingly, our group have reported a negative correlation between stool butyrate levels and senescent CD4 and CD8 T cells in older adults. To elucidate this connection further, in this thesis, we have examined the effect of butyrate on T cell senescent features in healthy young ( 35 years) and healthy old ( 65 years) adults using an in vitro model of proliferation-induced senescence. Evaluation of the potential anti-senescent effect of butyrate revealed significant reductions in the cell cycle arrest maker p53 and DNA damage marker -H2AX in aged T cells following 3 day culture with 1mM butyrate. We observed potential senomorphic properties of butyrate mediated via attenuation of SASP post butyrate treatment in aged T cells, alongside reductions in the expression of a key SASP regulator, the transcription factor nuclear factor kappa B (NF-B) at both the gene and protein level. Additionally, our findings demonstrated the potential ability of butyrate to decrease mitochondrial mass and ROS production in the T cells of older adults, however this requires further investigation. Consequently, we present butyrate supplementation as a future senomorphic postbiotic treatment to delay the onset of the senescent phenotype and help reduce the healthspan-lifespan gap by combating immunesenescence.","abstract_has_math":false,"creators":["Paddison Rees, Nia"],"institution":"University of Birmingham","degree_name":"m_sc","degree_level":"m_sc","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024-07","date_published":"2024-07","updated_at":"2026-11-19T09:32:33Z","subjects":["QR Microbiology","QR180 Immunology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/14312/7/PaddisonRees2024MScbyRes.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A14312","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Paddison Rees, Nia"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2024-07"]},{"key":"dc:date.issued","label":"Date","values":["2024-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Inflammation and Ageing"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/14312/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["m_sc"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["m_sc"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QR Microbiology","QR180 Immunology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/14312/7/PaddisonRees2024MScbyRes.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Ageing is accompanied by remodelling of the T cell pool and a hallmark of immune ageing is the expansion of senescent T cells in aged hosts. Senescent T cells express markers of DNA damage and cell cycle arrest markers, elevated production of pro-inflammatory cytokines as a result of the senescence-associated secretory phenotype (SASP), and accumulation of dysfunctional mitochondria. Importantly, animal studies have brought to light the causal role of senescent T cell accumulation in driving ageing of non-lymphoid organs; highlighting the need to combat the build-up of senescent T cells with advancing age. Advancing age is also characterised by changes in gut microbiome composition, one consequence of which is a reduction in short-chain fatty acid (SCFA) levels, the products of bacterial fermentation in the gut. Interestingly, our group have reported a negative correlation between stool butyrate levels and senescent CD4 and CD8 T cells in older adults. To elucidate this connection further, in this thesis, we have examined the effect of butyrate on T cell senescent features in healthy young ( 35 years) and healthy old ( 65 years) adults using an in vitro model of proliferation-induced senescence. Evaluation of the potential anti-senescent effect of butyrate revealed significant reductions in the cell cycle arrest maker p53 and DNA damage marker -H2AX in aged T cells following 3 day culture with 1mM butyrate. We observed potential senomorphic properties of butyrate mediated via attenuation of SASP post butyrate treatment in aged T cells, alongside reductions in the expression of a key SASP regulator, the transcription factor nuclear factor kappa B (NF-B) at both the gene and protein level. Additionally, our findings demonstrated the potential ability of butyrate to decrease mitochondrial mass and ROS production in the T cells of older adults, however this requires further investigation. Consequently, we present butyrate supplementation as a future senomorphic postbiotic treatment to delay the onset of the senescent phenotype and help reduce the healthspan-lifespan gap by combating immunesenescence."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Investigating the potential senomorphic properties of SCFA butyrate on aged T cells."]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Paddison Rees, Nia"],"dc:date":["2024-07"],"dc:date.issued":["2024-07"],"dc:description.abstract":["Ageing is accompanied by remodelling of the T cell pool and a hallmark of immune ageing is the expansion of senescent T cells in aged hosts. Senescent T cells express markers of DNA damage and cell cycle arrest markers, elevated production of pro-inflammatory cytokines as a result of the senescence-associated secretory phenotype (SASP), and accumulation of dysfunctional mitochondria. Importantly, animal studies have brought to light the causal role of senescent T cell accumulation in driving ageing of non-lymphoid organs; highlighting the need to combat the build-up of senescent T cells with advancing age. Advancing age is also characterised by changes in gut microbiome composition, one consequence of which is a reduction in short-chain fatty acid (SCFA) levels, the products of bacterial fermentation in the gut. Interestingly, our group have reported a negative correlation between stool butyrate levels and senescent CD4 and CD8 T cells in older adults. To elucidate this connection further, in this thesis, we have examined the effect of butyrate on T cell senescent features in healthy young ( 35 years) and healthy old ( 65 years) adults using an in vitro model of proliferation-induced senescence. Evaluation of the potential anti-senescent effect of butyrate revealed significant reductions in the cell cycle arrest maker p53 and DNA damage marker -H2AX in aged T cells following 3 day culture with 1mM butyrate. We observed potential senomorphic properties of butyrate mediated via attenuation of SASP post butyrate treatment in aged T cells, alongside reductions in the expression of a key SASP regulator, the transcription factor nuclear factor kappa B (NF-B) at both the gene and protein level. Additionally, our findings demonstrated the potential ability of butyrate to decrease mitochondrial mass and ROS production in the T cells of older adults, however this requires further investigation. Consequently, we present butyrate supplementation as a future senomorphic postbiotic treatment to delay the onset of the senescent phenotype and help reduce the healthspan-lifespan gap by combating immunesenescence."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/14312/7/PaddisonRees2024MScbyRes.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Inflammation and Ageing"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/14312/"],"dc:subject":["QR Microbiology","QR180 Immunology"],"dcterms:accessrights":["public"],"dc:title":["Investigating the potential senomorphic properties of SCFA butyrate on aged T cells."],"dc:type":["Thesis"],"dc:type.qualificationlevel":["m_sc"],"dc:type.qualificationname":["m_sc"]},"updated_at":"2026-11-19T09:32:33Z"}